Advertisement
U.S. markets closed
  • S&P Futures

    5,304.25
    -4.00 (-0.08%)
     
  • Dow Futures

    40,140.00
    -36.00 (-0.09%)
     
  • Nasdaq Futures

    18,465.00
    -38.75 (-0.21%)
     
  • Russell 2000 Futures

    2,145.20
    +6.80 (+0.32%)
     
  • Crude Oil

    83.11
    -0.06 (-0.07%)
     
  • Gold

    2,254.80
    +16.40 (+0.73%)
     
  • Silver

    25.10
    +0.18 (+0.74%)
     
  • EUR/USD

    1.0779
    -0.0014 (-0.13%)
     
  • 10-Yr Bond

    4.2060
    +0.0100 (+0.24%)
     
  • Vix

    13.01
    +0.23 (+1.80%)
     
  • GBP/USD

    1.2621
    -0.0001 (-0.01%)
     
  • USD/JPY

    151.2810
    -0.0910 (-0.06%)
     
  • Bitcoin USD

    70,779.53
    +1,274.58 (+1.83%)
     
  • CMC Crypto 200

    885.54
    0.00 (0.00%)
     
  • FTSE 100

    7,952.62
    +20.64 (+0.26%)
     
  • Nikkei 225

    40,406.09
    +238.02 (+0.59%)
     

Concur Technologies surges on analyst upgrade

Shares of Concur Technologies surge as analyst upgrades software company's rating

NEW YORK (AP) -- Shares of Concur Technologies rose Monday as Wunderlich Securities predicted solid growth next year for the human resources software company.

Analyst Richard Baldry raised his rating to "Buy" from "Hold." He also reiterated his share price target of $84 over the next 12 months to 18 months.

When reporting quarterly earnings last month, Concur, based in Redmond, Wash., predicted revenue in the next fiscal year to increase about 25 percent compared with 2012.

Concur's management has a track record of giving conservative guidance at the start of each fiscal year, Baldry told clients in a research note. He believes that Concur's forecast of a slower-than-expected growth rate in the first half of 2013 "should prove overly conservative."

During the second half of the year, Concur should see a 30 percent organic growth rate largely due to deals already signed, the analyst wrote. The company's valuation likely will climb steadily during the year.

THE SHARES: Concur Technologies Inc. rose $3.66, or 5.9 percent, to $65.48. The price has ranged between $47 and $76.15 in the past 52 weeks.

Advertisement